EP 4118079 A1 20230118 - PHARMACEUTICAL COMPOSITIONS OF LIPOIC ACID CHOLINE ESTER SALTS AND METHODS OF TREATMENT USING SAME
Title (en)
PHARMACEUTICAL COMPOSITIONS OF LIPOIC ACID CHOLINE ESTER SALTS AND METHODS OF TREATMENT USING SAME
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS LIPONSÄURE-CHOLINESTERSALZEN UND BEHANDLUNGSVERFAHREN DAMIT
Title (fr)
COMPOSITIONS PHARMACEUTIQUES DE SELS D'ESTER DE CHOLINE D'ACIDE LIPOÏQUE ET PROCÉDÉS DE TRAITEMENT LES UTILISANT
Publication
Application
Priority
- CN 2020079271 W 20200313
- US 202063013836 P 20200422
- IB 2021052092 W 20210312
Abstract (en)
[origin: US2021283171A1] The present disclosure provides salts of lipoic acid choline ester (LACE), crystalline forms thereof, and methods of use thereof. The present disclosure further provides pharmaceutical compositions of LACE salts and methods of use thereof.
IPC 8 full level
C07D 339/04 (2006.01); A61K 31/381 (2006.01); A61P 27/02 (2006.01); A61P 27/12 (2006.01)
CPC (source: CN EP IL KR US)
A61K 9/0048 (2013.01 - KR); A61K 9/08 (2013.01 - KR); A61K 31/381 (2013.01 - IL KR US); A61K 31/724 (2013.01 - IL US); A61K 47/02 (2013.01 - IL US); A61K 47/38 (2013.01 - IL KR US); A61K 47/40 (2013.01 - KR); A61P 27/02 (2017.12 - CN EP IL); A61P 27/10 (2017.12 - KR); A61P 27/12 (2017.12 - CN EP IL KR); C07C 309/30 (2013.01 - CN IL); C07C 309/72 (2013.01 - IL US); C07D 339/04 (2013.01 - CN EP IL KR US); C07B 2200/13 (2013.01 - CN IL KR US)
Citation (search report)
See references of WO 2021181361A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
US 11135239 B1 20211005; US 2021283171 A1 20210916; AU 2021235563 A1 20220922; BR 112022018043 A2 20221018; CA 3175077 A1 20210916; CN 113387923 A 20210914; CN 115279745 A 20221101; CO 2022012653 A2 20220909; CR 20220449 A 20221012; DO P2022000179 A 20220930; EC SP22069611 A 20221031; EP 4118079 A1 20230118; IL 295378 A 20221001; JO P20220211 A1 20230130; JP 2021147392 A 20210927; JP 2022058376 A 20220412; JP 7041298 B2 20220323; KR 20220146561 A 20221101; MX 2022011206 A 20220919; PE 20230242 A1 20230207; TW 202140435 A 20211101; TW I768760 B 20220621; US 11590158 B2 20230228; US 2021393671 A1 20211223; WO 2021181361 A1 20210916
DOCDB simple family (application)
US 202117199736 A 20210312; AU 2021235563 A 20210312; BR 112022018043 A 20210312; CA 3175077 A 20210312; CN 202110237490 A 20210303; CN 202180020651 A 20210312; CO 2022012653 A 20220906; CR 20220449 A 20210312; DO 2022000179 A 20220907; EC DI202269611 A 20220906; EP 21713132 A 20210312; IB 2021052092 W 20210312; IL 29537822 A 20220804; JO P20220211 A 20210312; JP 2021035929 A 20210308; JP 2021206074 A 20211220; KR 20227033130 A 20210312; MX 2022011206 A 20210312; PE 2022001926 A 20210312; TW 110108635 A 20210311; US 202117463391 A 20210831